Children with Juvenile Arthritis at Increased Risk for Cancer, but Research Casts Doubt on One Suspected Cause
Children with juvenile idiopathic arthritis, the most common form of childhood arthritis, appear at least twice as likely to develop cancer compared to children without JIA, irrespective of arthritis medications, according to new research from UAB published this week in the journal Arthritis and Rheumatism. This report casts some doubt on the role played by anti-TNF therapy, long considered a potential risk for cancer.
- Etanercept helps restore normal growth in children with juvenile arthritisWed, 3 Nov 2010, 10:35:07 EDT
- Biologics-naive juvenile idiopathic arthritis patients have elevated risk of cancerThu, 17 Jun 2010, 9:45:18 EDT
- Gene expression findings a step toward better classification and treatment of juvenile arthritisMon, 29 Jun 2009, 13:08:42 EDT
- Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawalThu, 11 Jun 2009, 11:26:40 EDT
- New clinical practice guidelines developed for juvenile idiopathic arthritis Wed, 30 Mar 2011, 12:03:56 EDT